Markets:

Overview

News

Currencies

International

Treasuries

Stoke Therapeutics, Inc. - Common Stock (NQ:STOK)

30.08 +0.68 (+2.31%)

Streaming Delayed Price Updated: 10:59 AM EST, Jan 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stoke Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

November 07, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

October 17, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

September 21, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

The Latest Analyst Ratings for Stoke Therapeutics ↗

July 31, 2023

Via Benzinga

What 8 Analyst Ratings Have To Say About Stoke Therapeutics ↗

June 26, 2023

Via Benzinga

Analyst Expectations for Stoke Therapeutics's Future ↗

June 08, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

Analyst Ratings for Stoke Therapeutics ↗

June 08, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Stoke Therapeutics Appoints Ian Smith to its Board of Directors

September 20, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress

September 05, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street ↗

August 16, 2023

This small-cap biotech might be a hidden gem.

Via The Motley Fool

Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates

August 07, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Why Shares of Stoke Therapeutics Plummeted Tuesday ↗

July 25, 2023

The company's shares fell after it released early trial results on its lead therapy.

Via The Motley Fool

Crude Oil Up 1%; Verizon Earnings Beat Views ↗

July 25, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 25, 2023

Via Benzinga

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 25, 2023

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Via Benzinga

Why Stoke Therapeutics Is Trading Lower Today? ↗

July 25, 2023

Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 25, 2023

Via Benzinga

Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome

July 25, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday ↗

July 21, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session. Digital World Acquisition Corp. (NASDAQ: DWAC) climbed 69%...

Via Benzinga

Stoke Therapeutics to Host Webinar to Present New Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome

July 21, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 24, 2023

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 21, 2023

Via Benzinga

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

June 16, 2023

From Stoke Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.